Start 30 days free, no card. Full Pro access for a month, then decide. Start free

Back to analysts list

Analyst

Cave Montazeri

Deutsche Bank · covers Financial Services

Period: Reporting periods mapped to calendar 2024 Q4 – 2026 Q2 (7 quarters).

Questions
21on tracked calls
Challenge rate
14%3 of 21 questions
Companies
5questioned at least once
Reporting periods
7with questions

These figures cover the whole profile: every tracked question, all reporting periods.

How to read these numbers

Challenge rate is the share of questions that pushed back, pressed for specifics or questioned management’s assumptions. It describes how questions were asked on the calls tracked here; it does not measure whether any view turned out to be right.

Rounding. Rates are rounded to whole percentages, so a small share can show as 0% even when some questions were challenging. The count beside each rate is exact; “none of N questions” means no question was challenging.

No questions recorded. “—” means there is nothing to calculate: no questions were recorded for that period on the calls tracked here. It does not mean there was no activity.

Fewer than 3 questions. A company-level rate is withheld when fewer than 3 questions were recorded for that company; the questions are still counted everywhere else.

Small samples. Profiles with fewer than 10 questions are marked Limited sample.

Reporting periods. Questions are grouped by the calendar quarter each company’s fiscal reporting period maps to, not by the date of the call. Periods without a calendar mapping are listed separately under their fiscal label.

Questions asked

Grouped by company, most questions first. Open a company to read its questions, newest reporting period first.

Showing 21 of 21 questions from 5 companies

ACGLArch Capital Group12 questions · 6 reporting periods · 2 of 12 challenging
ACGL company page →

Calendar 2026 Q2

Can you maybe give us some color on what kind of business you are sending to the retrocession market?

PricingCapital AllocationTranscript · FY2026 Q2 →
Show response

Morin explained Florida is the peak, highest-margin zone; Papadopoulo added PML could come down but would not commit to prior soft-market levels.

could you sustain above 100% payout throughout the soft cycle Not knowing how long soft cycle will last

ChallengingCapital AllocationTranscript · FY2026 Q2 →
Show response

Morin confirmed the capacity exists but declined to commit, flagging M&A and other capital uses as alternatives.

Calendar 2026 Q1

where are we in the underwriting clock today for cyber? And then structurally, like given the recent developments in AI

Competitive DynamicsInnovation & R&DTranscript · FY2026 Q1 →
Show response

Nicolas placed cyber at 3:00 PM on the underwriting clock, still OK but approaching caution. Views AI as accelerating the attacker-defender arms race rather than fundamentally changing the product. Sees increased systemic risk from scale acceleration. Taking careful approach in RDS scenarios.

is there any reason why you couldn't pay out of income, potentially even more, given that you're releasing capital when you're shrinking.

Capital AllocationTranscript · FY2026 Q1 →
Show response

Francois said nothing structural prevents higher payout, could buy back 100% of income, but that's not how they think about it. No set targets; react to stock price and liquidity conditions. Board's $3B reauthorization provides directional signal on ambition. No structural limitations beyond regulatory buyback rules.

Calendar 2025 Q4

whether you're more likely to be a net beneficiary from AI. Their improved efficiencies and smaller risk selection,

Innovation & R&DCompetitive DynamicsTranscript · FY2025 Q4 →
Show response

Nicolas agreed with premise that AI is more opportunity than threat. Specialty market complexity means it will take time for models to replicate underwriter behavior. Personal lines and SME may see faster AI adoption. Ultimate beneficiary will be consumers through passed-on savings.

if there is no growth, in 2026 I hope you guys see growth. But if there is no growth, you could distribute close to a 100% of the the capital you generate.

Capital AllocationTranscript · FY2025 Q4 →
Show response

Francois confirmed theoretically every dollar of income could become excess capital in a no-growth scenario. No set payout target. Willing to buy back more than 2025 levels if conditions warrant. Evaluated daily based on market conditions.

Calendar 2025 Q2

does that mean that your premium growth in reinsurance in the quarter would have been double digit this quarter, adjusting for that?

Show response

Francois confirmed adjusted reinsurance NWP growth would have been double digit, slightly above 8% GWP growth due to buying less reinsurance in some pockets. Property cat grew ~20% YoY, the main driver. Nicolas added demand increase in marketplace allowed securing attractive pricing.

Is it mainly like the tort reform from 2 years ago that are feeding through that's making the market a bit more attractive now?

PricingCompetitive DynamicsTranscript · FY2025 Q2 →
Show response

Nicolas explained tort reform improved local companies' attritional loss ratios from 50%+ to 20s, giving them money to buy reinsurance. Combined with storms hitting Florida, excess of loss business is attractive. Demand growing as companies buy closer to 100-200 year return levels.

Calendar 2025 Q1

I think it's pretty clear that the days of 30%-plus growth in NPW are behind us now as you become more selective.

Revenue GrowthCompetitive DynamicsTranscript · FY2025 Q1 →
Show response

Francois said adjusted for non-renewed structured deals ($147M) and timing differences ($103M), reinsurance growth was ~6-7%. Declines in cyber and specialty offset by property cat and casualty growth.

do you think we're just in the eye of the storm and there's more pain to come in the second half of 2025?

ChallengingCreditPricingTranscript · FY2025 Q1 →
Show response

Nicolas unequivocally stated more casualty pain is coming. The social inflation story has not fully played out. Arch is getting rate above trend on casualty but the market isn't yet safe to take broad share.

Calendar 2024 Q4

the city and commissions didn't change much at one one. Despite the adverse development. Carriers continue to face, My question is, what's the incremental supply of casualty reinsurance

PricingCompetitive DynamicsTranscript · FY2024 Q4 →
Show response

Nicolas acknowledged ceding commissions haven't dropped despite the adverse casualty environment because there's still ample supply. Arch is more bullish on primary E&S side where they have true expertise.

can you give us an update on how the integration of Medcorp is going? And if the growth prospects how that's evolving versus your expectations prior to the deal

Show response

Nicolas confirmed integration on track, performance as expected. Double-digit rate increases in Midcorp property and liability lines. Program book remediation underway.

AONAon4 questions · 2 reporting periods · 0 of 4 challenging
AON company page →

Calendar 2026 Q1

will those efficiencies and better analytical tools become commoditized? Or is there like a real moat to being early

Competitive DynamicsInnovation & R&DTranscript · FY2026 Q1 →
Show response

Greg emphasized the moat is organizational (Risk Capital + Human Capital integration), proprietary data quality, and continuous analyzer iteration through 10+ versions, not just technology.

Could you kind of remind us like how that came about? Is that something that kind of you want to keep

Competitive DynamicsRevenue GrowthTranscript · FY2026 Q1 →
Show response

Edmund explained personal lines came through acquisitions and is being actively divested. Cash from dispositions exceeded $730M in 2024 as AON focuses on core Risk Capital and Human Capital.

Calendar 2025 Q1

is there something specific that you think the street is underappreciating maybe in terms, like, the power of the Aon United platform? Your ABS capabilities, or the three by three plan?

Show response

Greg described a next-generation client experience enabled by 15 years of platform investment, $1B in ABS/AI spend, and the 3x3 acceleration. Plans to showcase tangible client examples and generative AI capabilities at the June 9 event.

the second quarter EPS guidance that you gave us, 15% to 18% EPS growth. Is that is the baseline the $2.93 reported or is there any adjustments we need to make?

Guidance ReliabilityTranscript · FY2025 Q1 →
Show response

Edmund confirmed $2.93 as the correct baseline and noted the Q2 EPS guidance was a one-time accommodation for the unique NFP close timing impact on modeling.

AJGArthur J. Gallagher & Co.2 questions · 1 reporting period · 1 of 2 challenging
AJG company page →

Calendar 2025 Q1

I think you mentioned 4% if I remember correctly, I guess it’s not a bad number in absolute terms, but it is a bit of a drag

ChallengingGeographic ExpansionRevenue GrowthTranscript · FY2025 Q1 →
Show response

Doug explained Australia/NZ seasonally slow in Q1, UK retail tracking similar to US retail. Canada roughly flat. The lower international number is seasonal, not structural.

I know you guys have a pretty good real-time pulse on the economy. Earlier in your prepared remarks, you mentioned the U.S. labor market was still strong

Trade TariffsMacroeconomicTranscript · FY2025 Q1 →
Show response

Pat said tariff concern is very client-specific depending on supply chain and product mix. Consternation creates advisory opportunity for Gallagher across captives, retentions, etc.

METMetLife2 questions · 1 reporting period · 0 of 2 challenging
MET company page →

Calendar 2025 Q2

Could you give us an update on your implementation of GenAI in your processes, which parts of your business do you think can benefit most from GenAI

Innovation & R&DMarginTranscript · FY2025 Q2 →
Show response

Michel Khalaf highlighted multiyear tech modernization enabling AI force multiplication. Biggest impacts in application development, call centers, and claims. Combination of established partnerships with key AI players and specialized plug-and-play solutions. Still early days but full production on many initiatives.

Q2 wasn't your best quarter for PRT, but I appreciate that's a lumpy business, especially at the jumbo land

DemandRevenue GrowthTranscript · FY2025 Q2 →
Show response

Ramy Tadros noted YTD PRT of $2.2B with jumbo cases expected in H2. UK participation is via longevity swaps ($30B balances) and funded reinsurance. Fundamental drivers, funding levels, derisking desire, frozen plans, remain intact for medium-term growth.

PRUPrudential Financial1 question · 1 reporting period · 0 of 1 challenging
PRU company page →

Calendar 2025 Q3

Do you think that the new generation of AI tools are adding more urgency to invest even more in tech right now than, let's say, 3 years ago

Innovation & R&DCost PressureTranscript · FY2025 Q3 →
Show response

Andy confirmed investments are ramping up due to better quality tools and clear value. Two focus areas: customer/adviser experience personalization and organizational efficiency through employee productivity and process simplification. Declined to quantify spend citing competitive sensitivity.

Challenge rate by company

Every company this analyst questioned, most questions first. A company-level rate is shown from 3 questions; below that it is withheld.

CompanyQuestionsChallenge rate
ACGL Arch Capital Group1217%2 of 12 questions
AON Aon40%none of 4 questions
AJG Arthur J. Gallagher & Co.2—Rate withheld: fewer than 3 questions
MET MetLife2—Rate withheld: fewer than 3 questions
PRU Prudential Financial1—Rate withheld: fewer than 3 questions
  • ACGL
    Arch Capital Group · 12 questions
    17%2 of 12 questions
  • AON
    Aon · 4 questions
    0%none of 4 questions
  • AJG
    Arthur J. Gallagher & Co. · 2 questions
    —rate withheld: under 3 questions
  • MET
    MetLife · 2 questions
    —rate withheld: under 3 questions
  • PRU
    Prudential Financial · 1 question
    —rate withheld: under 3 questions

Activity by reporting period

Questions recorded for each calendar quarter that companies’ reporting periods map to (not the call date), with the challenge rate for that period. Periods inside the range with no questions are shown as “No questions recorded”.

Questions by calendar reporting period
Calendar periodQuestionsChallenge rateCompanies
2024 Q420%none of 2 questions1
2025 Q1633%2 of 6 questions3
2025 Q240%none of 4 questions2
2025 Q310%none of 1 question1
2025 Q420%none of 2 questions1
2026 Q140%none of 4 questions2
2026 Q2250%1 of 2 questions1
  1. 2024 Q42 questions · challenge rate 0% (none of 2 questions) · 1 company
  2. 2025 Q16 questions · challenge rate 33% (2 of 6 questions) · 3 companies
  3. 2025 Q24 questions · challenge rate 0% (none of 4 questions) · 2 companies
  4. 2025 Q31 question · challenge rate 0% (none of 1 question) · 1 company
  5. 2025 Q42 questions · challenge rate 0% (none of 2 questions) · 1 company
  6. 2026 Q14 questions · challenge rate 0% (none of 4 questions) · 2 companies
  7. 2026 Q22 questions · challenge rate 50% (1 of 2 questions) · 1 company

Topics

Topics tagged on this analyst’s questions.

  • Competitive Dynamics7
  • Innovation & R&D6
  • Revenue Growth6
  • Pricing4
  • Capital Allocation4
  • Cost Pressure1
  • Margin1
  • Demand1
  • Credit1
  • Geographic Expansion1
Show all 14 topics
  • Trade Tariffs1
  • Macroeconomic1
  • Guidance Reliability1
  • M&A1